These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17663792)
41. Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in Sinnige T; Meisl G; Michaels TCT; Vendruscolo M; Knowles TPJ; Morimoto RI Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836595 [TBL] [Abstract][Full Text] [Related]
42. Reversible Regulation of Polyubiquitin Gene Han SW; Jung BK; Park SH; Ryu KY Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261719 [TBL] [Abstract][Full Text] [Related]
43. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Gidalevitz T; Ben-Zvi A; Ho KH; Brignull HR; Morimoto RI Science; 2006 Mar; 311(5766):1471-4. PubMed ID: 16469881 [TBL] [Abstract][Full Text] [Related]
44. E2 enzymes: expanding the 'ubi-verse' of immune signaling. Ma A; Turer E Nat Immunol; 2006 Sep; 7(9):903-4. PubMed ID: 16924251 [No Abstract] [Full Text] [Related]
45. UBE2A/B is the trans-acting factor mediating mechanotransduction and contact inhibition. Feng M; Wang J; Li K; Nakamura F Biochem J; 2023 Oct; 480(20):1659-1674. PubMed ID: 37818922 [TBL] [Abstract][Full Text] [Related]
46. Filter Retardation Assay for Detecting and Quantifying Polyglutamine Aggregates Using Sin O; Mata-Cabana A; Seinstra RI; Nollen EAA Bio Protoc; 2018 Oct; 8(19):. PubMed ID: 30450365 [TBL] [Abstract][Full Text] [Related]
47. Individual point mutations in two ERAD E2 ubiquitin-conjugating enzymes do not affect Oswald M; Hulsey-Vincent H; Dahlberg CL MicroPubl Biol; 2020 Nov; 2020():. PubMed ID: 33274319 [No Abstract] [Full Text] [Related]
48. Polyglutamine makes the switch. Mushegian AA Sci Signal; 2017 Mar; 10(472):. PubMed ID: 28351951 [TBL] [Abstract][Full Text] [Related]
50. Ubiquitin-modifying enzymes in Huntington's disease. Sap KA; Geijtenbeek KW; Schipper-Krom S; Guler AT; Reits EA Front Mol Biosci; 2023; 10():1107323. PubMed ID: 36926679 [TBL] [Abstract][Full Text] [Related]
51. Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson's disease models. Su J; Huang P; Qin M; Lu Q; Sang X; Cai Y; Wang Y; Liu F; Wu R; Wang X; Jiang X; Wang J; Sun Q; Chen S; Xu J Cell Death Dis; 2018 Oct; 9(10):1020. PubMed ID: 30282965 [TBL] [Abstract][Full Text] [Related]
52. Morphological remodeling of Vayndorf EM; Scerbak C; Hunter S; Neuswanger JR; Toth M; Parker JA; Neri C; Driscoll M; Taylor BE NPJ Aging Mech Dis; 2016; 2():16001-. PubMed ID: 27347427 [TBL] [Abstract][Full Text] [Related]
53. Dopamine signaling promotes the xenobiotic stress response and protein homeostasis. Joshi KK; Matlack TL; Rongo C EMBO J; 2016 Sep; 35(17):1885-901. PubMed ID: 27261197 [TBL] [Abstract][Full Text] [Related]
55. Induction of cytoprotective pathways is central to the extension of lifespan conferred by multiple longevity pathways. Shore DE; Carr CE; Ruvkun G PLoS Genet; 2012; 8(7):e1002792. PubMed ID: 22829775 [TBL] [Abstract][Full Text] [Related]
56. Ubiquitination is involved in secondary growth, not initial formation of polyglutamine protein aggregates in C. elegans. Skibinski GA; Boyd L BMC Cell Biol; 2012 Apr; 13():10. PubMed ID: 22494772 [TBL] [Abstract][Full Text] [Related]
57. UEV-1 is an ubiquitin-conjugating enzyme variant that regulates glutamate receptor trafficking in C. elegans neurons. Kramer LB; Shim J; Previtera ML; Isack NR; Lee MC; Firestein BL; Rongo C PLoS One; 2010 Dec; 5(12):e14291. PubMed ID: 21179194 [TBL] [Abstract][Full Text] [Related]
58. E1 ubiquitin-activating enzyme UBA-1 plays multiple roles throughout C. elegans development. Kulkarni M; Smith HE PLoS Genet; 2008 Jul; 4(7):e1000131. PubMed ID: 18636104 [TBL] [Abstract][Full Text] [Related]